Advertisement
Nano-X Imaging Ltd.

Nano-X Imaging Ltd. Fundamental Analysis

NNOXNASDAQ
HealthcareMedical - Devices
$1.36
$0.20(17.24%)
U.S. Market opens in 3h 31m
Advertisement

Nano-X Imaging Ltd. Fundamental Analysis

Nano-X Imaging Ltd. (NNOX) shows moderate financial fundamentals with a PE ratio of -1.15, profit margin of -5.24%, and ROE of -51.88%. The company generates $0.0B in annual revenue with strong year-over-year growth of 15.40%.

Key Strengths

Cash Position45.65%
PEG Ratio0.04
Current Ratio3.64

Areas of Concern

ROE-51.88%
Operating Margin-4.23%
We analyze NNOX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -401.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-401.1/100

We analyze NNOX's fundamental strength across five key dimensions:

Efficiency Score

Weak

NNOX struggles to generate sufficient returns from assets.

ROA > 10%
-52.17%

Valuation Score

Excellent

NNOX trades at attractive valuation levels.

PE < 25
-1.15
PEG Ratio < 2
0.04

Growth Score

Moderate

NNOX shows steady but slowing expansion.

Revenue Growth > 5%
15.40%
EPS Growth > 10%
-27.47%

Financial Health Score

Excellent

NNOX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.06
Current Ratio > 1
3.64

Profitability Score

Weak

NNOX struggles to sustain strong margins.

ROE > 15%
-5188.00%
Net Margin ≥ 15%
-5.24%
Positive Free Cash Flow
No

Key Financial Metrics

Is NNOX Expensive or Cheap?

P/E Ratio

NNOX trades at -1.15 times earnings. This suggests potential undervaluation.

-1.15

PEG Ratio

When adjusting for growth, NNOX's PEG of 0.04 indicates potential undervaluation.

0.04

Price to Book

The market values Nano-X Imaging Ltd. at 0.72 times its book value. This may indicate undervaluation.

0.72

EV/EBITDA

Enterprise value stands at -2.56 times EBITDA. This is generally considered low.

-2.56

How Well Does NNOX Make Money?

Net Profit Margin

For every $100 in sales, Nano-X Imaging Ltd. keeps $-5.24 as profit after all expenses.

-5.24%

Operating Margin

Core operations generate -4.23 in profit for every $100 in revenue, before interest and taxes.

-4.23%

ROE

Management delivers $-51.88 in profit for every $100 of shareholder equity.

-51.88%

ROA

Nano-X Imaging Ltd. generates $-52.17 in profit for every $100 in assets, demonstrating efficient asset deployment.

-52.17%

Following the Money - Real Cash Generation

Operating Cash Flow

Nano-X Imaging Ltd. generates limited operating cash flow of $-45.49M, signaling weaker underlying cash strength.

$-45.49M

Free Cash Flow

Nano-X Imaging Ltd. generates weak or negative free cash flow of $-51.05M, restricting financial flexibility.

$-51.05M

FCF Per Share

Each share generates $-0.73 in free cash annually.

$-0.73

FCF Yield

NNOX converts -54.16% of its market value into free cash.

-54.16%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.15

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.72

vs 25 benchmark

P/S Ratio

Price to sales ratio

6.30

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.06

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.64

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.52

vs 25 benchmark

ROA

Return on assets percentage

-0.52

vs 25 benchmark

ROCE

Return on capital employed

-0.47

vs 25 benchmark

How NNOX Stacks Against Its Sector Peers

MetricNNOX ValueSector AveragePerformance
P/E Ratio-1.1529.74 Better (Cheaper)
ROE-51.88%391.00% Weak
Net Margin-523.83%-11426.00% (disorted) Weak
Debt/Equity0.060.77 Strong (Low Leverage)
Current Ratio3.645.10 Strong Liquidity
ROA-52.17%-260.00% (disorted) Weak

NNOX outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Nano-X Imaging Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

5.10%

Industry Style: Defensive, Growth, Innovation

Growing

FCF CAGR

-4.47%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ